Cerebellar tDCS and Balance Training in PwMS

Multiple Sclerosis Clinical Trial

Official title:

The Effects of 2 mA and 4 mA Cerebellar Transcranial Direct Current Stimulation and Balance Training to Reduce Fall Risk in People With Multiple Sclerosis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04391023
• Other study ID #: 201912430
• Status: Completed
• Phase: N/A
• Start date: September 26, 2022
• Est. completion date: July 16, 2023

Study information

• Verified date: October 2023
• Source: University of Iowa
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Many people with multiple sclerosis (PwMS) have decreased balance and postural control, gait deficits, and a high frequency of falls. High fall rates and mobility impairments pose a significant risk to the independence and quality of life of PwMS. Therefore, effective interventions to improve balance and postural control are urgently needed to decrease the frequency of falls in PwMS. Balance training has been demonstrated to significantly improve postural control and gait in PwMS. One possible treatment modality to amplify the effects of balance training is transcranial direct current stimulation (tDCS), a non-invasive means to increase cortical excitability and potentially prime the brain for task specific learning. The cerebellum plays a vital role in balance and posture and may be an important target structure for tDCS studies seeking to reduce fall risk. Studies have shown that anodal cerebellar tDCS is effective in improving balance control in older adults with high fall risk and patients with chronic stroke. However, the most effective tDCS intensity and the duration of the effects on balance control has not been established. Moreover, no study has combined cerebellar tDCS and balance training to reduce fall risk in PwMS. The purpose of this study is to investigate the effects of cerebellar transcranial direct current stimulation (tDCS) on fall risk in people with relasping-remitting multiple sclerosis. We will conduct tDCS or SHAM followed by balance training on 4 consecutive days. We will evaluate fall risk with well-established functional tasks, such as the Berg Balance Scale, Timed Up and Go (TUG), the six minute walk test (6MWT), and static posturography. Prospective participants, men and women with relasping-remitting MS, will be recruited. To accomplish this study, 30 participants will be randomly assigned into 3 groups (2 mA tDCS, 4 mA tDCS, or SHAM). This study involves 4 daily visits at the Integrative Neurophysiology Lab at the same time of day for each subject and three follow-up visits. The duration of visit 1 will be approximately 2.5 hours and the duration of visits 2-4 will be approximately 1.5 hours. Visit 5, 6, and 7 will be approximately 24 hours, 1 week, and 3 weeks, respectively, after visit 4 and will last approximately 1.5 hours. During tDCS sessions, participants will undergo either Sham, 2 mA, and 4 mA tDCS for 20 minutes followed by balance training.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 14
• Est. completion date: July 16, 2023
• Est. primary completion date: July 16, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

1. medically diagnosed with relasping-remitting multiple sclerosis

2. 18-70 years of age

3. moderate disability (score of 2-6 on the Patient Determined Disease Scale [PPDS])

4. self-reported differences in function between legs, have fallen within the last year

5. able to walk for 6 mins, and not taking any psychoactive medication.

Exclusion Criteria:

1. relapse within the last 60 days

2. have changed disease modifying medications in the last 45 days

3. are currently pregnant

4. have a concurrent neurological or neuromuscular disease

5. have been hospitalized within the last 90 days

6. have any contraindications for the tDCS device (i.e., pacemakers or metal implants)

7. are unable to understand/sign the consent form.

Related Conditions & MeSH terms

• Multiple Sclerosis
• Sclerosis

Intervention

Device:
• Sham Transcranial Direct Current Stimulation (tDCS)
tDCS is a non-invasive brain stimulation technique in which a very weak electrical current (2 mA) is applied to the scalp at the beginning of the session and then remains at 0 mA for the duration of the session to control for placebo-like effects. The anode and cathode will both be placed over the cerebellum.

Behavioral:
• Balance Training
The balance training protocol will include balance training exercises on both compliant (i.e., foam pad and trampoline) and firm surfaces.

Device:
• 2 mA Transcranial Direct Current Stimulation
tDCS is a non-invasive brain stimulation technique in which very weak electrical current (2 mA) is applied to the scalp for 20 minutes. The anode and cathode will both be placed over the cerebellum.
• 4 mA Transcranial Direct Current Stimulation
tDCS is a non-invasive brain stimulation technique in which very weak electrical current (4 mA) is applied to the scalp for 20 minutes. The anode and cathode will both be placed over the cerebellum.

Locations

Country	Name	City	State
United States	University of Iowa	Iowa City	Iowa

Sponsors (1)

Lead Sponsor	Collaborator
University of Iowa

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Score on the Berg Balance Scale	Assess balance and fall risk in adults	Through study completion, up to 6 months.
Primary	Time to complete the Timed Up and Go Test (TUG)	Stand up from a seated position, walk to a marker	Through study completion, up to 6 months.
Secondary	Outcomes on Electromyography (EMG)	Investigation of muscle activation strategies during balance and walking tasks	Through study completion, up to 6 months.
Secondary	Time to complete the Six Minute Walk Test (6MWT)	Walk back and forth between two markers spaced 30 meters apart for 6 minutes.	Through study completion, up to 6 months.
Secondary	Score on the Fatigue Severity Scale (FSS)	Scale that examines the severity of fatigue and the impact on the participant's activities. There are nine statements about the participant's fatigue over the last week. They are asked to rate the severity on a scale from 1 to 7 (1 disagree, 7 agree) for each question.	Through study completion, up to 6 months.
Secondary	Outcomes on Static Posturography	Measures postural control	Through study completion, up to 6 months.
Secondary	Score on Patient Determined Disease Steps (PDDS)	Questionnaire to determine self-reported disability in people with multiple sclerosis. People are asked to choose one out of nine options that best describes how well they walk. 0 is "normal" and 8 is "bedridden."	Through study completion, up to 6 months.